{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:15:44Z","timestamp":1792185344829,"version":"4.4.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11926-020-0887-9","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T03:02:38Z","timestamp":1583204558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Pediatric APS: State of the Art"],"prefix":"10.1007","volume":"22","author":[{"given":"Arzu","family":"Soybilgic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Avcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"issue":"2","key":"887_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"887_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1546-0096-11-5","volume":"11","author":"NM Wulffraat","year":"2013","unstructured":"Wulffraat NM, Vastert B, Consortium S. Time to share. Pediatr Rheumatol Online J. 2013;11(1):5. https:\/\/doi.org\/10.1186\/1546-0096-11-5.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"887_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","volume":"76","author":"Noortje Groot","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017;76(10):1637\u201341. https:\/\/doi.org\/10.1136\/annrheumdis-2016-211001Recent, international evidence-based recommendations based on EULAR operating procedures, to facilitate improvement and uniformity of care.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"887_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309\u201311. https:\/\/doi.org\/10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"887_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1191\/096120301701548427","volume":"10","author":"T Avcin","year":"2001","unstructured":"Avcin T, Cimaz R, Meroni PL. Do we need an international consensus statement on classification criteria for the antiphospholipid syndrome in the paediatric population? Lupus. 2001;10(12):897\u20138. https:\/\/doi.org\/10.1191\/096120301701548427.","journal-title":"Lupus."},{"issue":"4","key":"887_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019\u201327.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"887_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1055\/s-2007-973766","volume":"27","author":"L Angelini","year":"1996","unstructured":"Angelini L, Zibordi F, Zorzi G, Nardocci N, Caporali R, Ravelli A, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics. 1996;27(3):149\u201353. https:\/\/doi.org\/10.1055\/s-2007-973766.","journal-title":"Neuropediatrics."},{"issue":"5","key":"887_CR8","doi-asserted-by":"publisher","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","volume":"122","author":"T Avcin","year":"2008","unstructured":"Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008;122(5):e1100\u20137. https:\/\/doi.org\/10.1542\/peds.2008-1209Most comprehensive descriptive characteristics of pediatric APS from an international registry.","journal-title":"Pediatrics"},{"issue":"1","key":"887_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1191\/0961203302lu146rr","volume":"11","author":"T Avcin","year":"2002","unstructured":"Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus. 2002;11(1):4\u201310. https:\/\/doi.org\/10.1191\/0961203302lu146rr.","journal-title":"Lupus."},{"key":"887_CR10","unstructured":"15th Paediatric Rheumatology European Society (PreS) Congress London, UK. 14\u201317 September 2008. Abstracts. Pediatric rheumatology online journal. 2008;6 Suppl 1:P1-S34."},{"issue":"2 Pt 1","key":"887_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.96.2.291","volume":"96","author":"R Nuss","year":"1995","unstructured":"Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995;96(2 Pt 1):291\u20134.","journal-title":"Pediatrics."},{"issue":"5","key":"887_CR12","first-page":"286","volume":"14","author":"A Zamora-Ustaran","year":"2012","unstructured":"Zamora-Ustaran A, Escarcega-Alarcon RO, Garcia-Carrasco M, Faugier E, Mendieta-Zeron S, Mendoza-Pinto C, et al. Antiphospholipid syndrome in Mexican children. Isr Med Assoc J. 2012;14(5):286\u20139.","journal-title":"Isr Med Assoc J"},{"issue":"5","key":"887_CR13","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s10067-017-3776-5","volume":"37","author":"J Ma","year":"2018","unstructured":"Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clin Rheumatol. 2018;37(5):1295\u2013303. https:\/\/doi.org\/10.1007\/s10067-017-3776-5.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"887_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","volume":"40","author":"T Avcin","year":"2001","unstructured":"Avcin T, Ambrozic A, Kuhar M, Kveder T, Rozman B. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology. 2001;40(5):565\u201373.","journal-title":"Rheumatology."},{"issue":"4","key":"887_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-015-0504-5","volume":"17","author":"CL Aguiar","year":"2015","unstructured":"Aguiar CL, Soybilgic A, Avcin T, Myones BL. Pediatric antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17(4):27. https:\/\/doi.org\/10.1007\/s11926-015-0504-5.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"887_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0022-3476(99)70416-6","volume":"134","author":"C Male","year":"1999","unstructured":"Male C, Lechner K, Eichinger S, Kyrle PA, Kapiotis S, Wank H, et al. Clinical significance of lupus anticoagulants in children. J Pediatr. 1999;134(2):199\u2013205.","journal-title":"J Pediatr"},{"issue":"4 Pt 2","key":"887_CR17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1542\/peds.89.4.691","volume":"89","author":"CD Burk","year":"1992","unstructured":"Burk CD, Miller L, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics. 1992;89(4 Pt 2):691\u20135.","journal-title":"Pediatrics."},{"issue":"Suppl 2","key":"887_CR18","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1177\/096120339800700213","volume":"7","author":"AE Gharavi","year":"1998","unstructured":"Gharavi AE, Pierangeli SS. Origin of antiphospholipid antibodies: induction of aPL by viral peptides. Lupus. 1998;7(Suppl 2):S52\u20134.","journal-title":"Lupus."},{"issue":"3","key":"887_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11926-007-0034-x","volume":"9","author":"T Avcin","year":"2007","unstructured":"Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep. 2007;9(3):212\u20138.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"887_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s00431-006-0117-0","volume":"165","author":"H Mizumoto","year":"2006","unstructured":"Mizumoto H, Maihara T, Hiejima E, Shiota M, Hata A, Seto S, et al. Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature. Eur J Pediatr. 2006;165(7):484\u20138. https:\/\/doi.org\/10.1007\/s00431-006-0117-0.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"887_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.vaccine.2004.07.029","volume":"23","author":"R Mormile","year":"2004","unstructured":"Mormile R, D'Alterio V, Treccagnoli G, Sorrentino P. Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children? Vaccine. 2004;23(5):567\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.029.","journal-title":"Vaccine."},{"issue":"Suppl 1","key":"887_CR22","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1053\/j.seminhematol.2016.04.014","volume":"53","author":"M Bizjak","year":"2016","unstructured":"Bizjak M, Bruck O, Kanduc D, Praprotnik S, Shoenfeld Y. Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine. Semin Hematol. 2016;53(Suppl 1):S48\u201350. https:\/\/doi.org\/10.1053\/j.seminhematol.2016.04.014.","journal-title":"Semin Hematol"},{"issue":"2","key":"887_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0961203311429550","volume":"21","author":"A Katzav","year":"2012","unstructured":"Katzav A, Kivity S, Blank M, Shoenfeld Y, Chapman J. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome. Lupus. 2012;21(2):210\u20136. https:\/\/doi.org\/10.1177\/0961203311429550.","journal-title":"Lupus."},{"issue":"4","key":"887_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/BOR.0b013e32835448b8","volume":"24","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias P, Blank M, Anaya JM, Shoenfeld Y. Infections and vaccines in the etiology of antiphospholipid syndrome. Curr Opin Rheumatol. 2012;24(4):389\u201393. https:\/\/doi.org\/10.1097\/BOR.0b013e32835448b8.","journal-title":"Curr Opin Rheumatol"},{"issue":"4 Pt 1","key":"887_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.94.4.500","volume":"94","author":"L Angelini","year":"1994","unstructured":"Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics. 1994;94(4 Pt 1):500\u20133.","journal-title":"Pediatrics."},{"issue":"4","key":"887_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ajh.2830480407","volume":"48","author":"MJ Manco-Johnson","year":"1995","unstructured":"Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Am J Hematol. 1995;48(4):240\u20133.","journal-title":"Am J Hematol"},{"issue":"7","key":"887_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1055\/s-0031-1297171","volume":"37","author":"G Kenet","year":"2011","unstructured":"Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, et al. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011;37(7):802\u20139. https:\/\/doi.org\/10.1055\/s-0031-1297171A meta-analysis describing the impact of antiphospholipid antibodies on the risk of thrombotic events in children.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"887_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1538-7836.2007.02454.x","volume":"5","author":"V Pengo","year":"2007","unstructured":"Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost. 2007;5(5):925\u201330. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02454.x.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"887_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5045\/br.2014.49.2.85","volume":"49","author":"MO Nakashima","year":"2014","unstructured":"Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res. 2014;49(2):85\u201394. https:\/\/doi.org\/10.5045\/br.2014.49.2.85.","journal-title":"Blood Res"},{"issue":"2","key":"887_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/08916939908994054","volume":"31","author":"J Guerin","year":"1999","unstructured":"Guerin J, Casey E, Feighery C, Jackson J. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Autoimmunity. 1999;31(2):109\u201316.","journal-title":"Autoimmunity."},{"issue":"13","key":"887_CR31","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1182\/blood-2005-05-2048","volume":"106","author":"C Male","year":"2005","unstructured":"Male C, Foulon D, Hoogendoorn H, Vegh P, Silverman E, David M, et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood. 2005;106(13):4152\u20138. https:\/\/doi.org\/10.1182\/blood-2005-05-2048.","journal-title":"Blood."},{"issue":"4","key":"887_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MBC.0b013e32809cc95a","volume":"18","author":"B Tavil","year":"2007","unstructured":"Tavil B, Ozyurek E, Gumruk F, Cetin M, Gurgey A. Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagul Fibrinolysis. 2007;18(4):347\u201352. https:\/\/doi.org\/10.1097\/MBC.0b013e32809cc95a.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"887_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1055\/s-0037-1613120","volume":"87","author":"M Bonduel","year":"2002","unstructured":"Bonduel M, Hepner M, Sciuccati G, Pieroni G, Feliu-Torres A, Mardaraz C, et al. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost. 2002;87(6):972\u20137.","journal-title":"Thromb Haemost"},{"issue":"11","key":"887_CR34","first-page":"2385","volume":"30","author":"M Hudson","year":"2003","unstructured":"Hudson M, Herr AL, Rauch J, Neville C, Chang E, Ibrahim R, et al. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol. 2003;30(11):2385\u201391.","journal-title":"J Rheumatol"},{"issue":"5","key":"887_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1651-2227.1996.tb14098.x","volume":"85","author":"S Kontiainen","year":"1996","unstructured":"Kontiainen S, Miettinen A, Seppala I, Verkasalo M, Maenpaa J. Antiphospholipid antibodies in children. Acta Paediatr. 1996;85(5):614\u20135.","journal-title":"Acta Paediatr"},{"issue":"2","key":"887_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/ard.2010.137281","volume":"70","author":"L Andreoli","year":"2011","unstructured":"Andreoli L, Nalli C, Motta M, Norman GL, Shums Z, Encabo S, et al. Anti-beta(2)-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4\/5: might it be the reason for their 'innocent' profile? Ann Rheum Dis. 2011;70(2):380\u20133. https:\/\/doi.org\/10.1136\/ard.2010.137281.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"887_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/intimm\/dxf043","volume":"14","author":"A Ambrozic","year":"2002","unstructured":"Ambrozic A, Avicin T, Ichikawa K, Kveder T, Matsuura E, Hojnik M, et al. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol. 2002;14(7):823\u201330. https:\/\/doi.org\/10.1093\/intimm\/dxf043.","journal-title":"Int Immunol"},{"issue":"1\u20132","key":"887_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12026-014-8578-0","volume":"61","author":"A Artenjak","year":"2015","unstructured":"Artenjak A, Locatelli I, Brelih H, Simonic DM, Ulcova-Gallova Z, Swadzba J, et al. Immunoreactivity and avidity of IgG anti-beta2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of beta2-glycoprotein I. Immunol Res. 2015;61(1\u20132):35\u201344. https:\/\/doi.org\/10.1007\/s12026-014-8578-0.","journal-title":"Immunol Res"},{"issue":"7","key":"887_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/0961203312440057","volume":"21","author":"S Cucnik","year":"2012","unstructured":"Cucnik S, Kveder T, Artenjak A, Ulcova Gallova Z, Swadzba J, Musial J, et al. Avidity of anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus. 2012;21(7):764\u20135. https:\/\/doi.org\/10.1177\/0961203312440057.","journal-title":"Lupus."},{"issue":"11","key":"887_CR40","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1177\/0961203311406308","volume":"20","author":"S Cucnik","year":"2011","unstructured":"Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, et al. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 2011;20(11):1166\u201371. https:\/\/doi.org\/10.1177\/0961203311406308.","journal-title":"Lupus."},{"issue":"12","key":"887_CR41","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.revmed.2011.07.014","volume":"32","author":"G Moulis","year":"2011","unstructured":"Moulis G, Delavigne K, Huguet F, Fortenfant F, Beyne-Rauzy O, Adoue D. Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome. Rev Med Interne. 2011;32(12):724\u20139. https:\/\/doi.org\/10.1016\/j.revmed.2011.07.014.","journal-title":"Rev Med Interne"},{"issue":"9","key":"887_CR42","first-page":"821","volume":"43","author":"M Sakai","year":"2002","unstructured":"Sakai M, Shirahata A, Akatsuka J, Fujisawa K, Ohkawa H, Konishi S, et al. Antiphospholipid antibodies in children with idiopathic thrombocytopenic purpura. [Rinsho ketsueki]. Jpn J Clin Hematol. 2002;43(9):821\u20137.","journal-title":"Jpn J Clin Hematol"},{"issue":"1","key":"887_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/10245332.2018.1532649","volume":"24","author":"L Frison","year":"2019","unstructured":"Frison L, Lombardi A, Caputo I, Semenzato G, Fabris F, Vianello F. Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study. Hematology. 2019;24(1):134\u20138. https:\/\/doi.org\/10.1080\/10245332.2018.1532649.","journal-title":"Hematology."},{"issue":"9","key":"887_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00043426-200309000-00017","volume":"25","author":"T Avcin","year":"2003","unstructured":"Avcin T, Jazbec J, Kuhar M, Zupancic M, Rozman B. Evans syndrome associated with antiphospholipid antibodies. J Pediatr Hematol Oncol. 2003;25(9):755\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"887_CR45","first-page":"282","volume":"95","author":"U Anurathapan","year":"2012","unstructured":"Anurathapan U, Sasanakul W, Sirachainan N, Kasemkosolsri C, Jaovisidha S, Chuansumrit A. Acquired hypoprothrombinemia inducing bleeding in a girl with transient antiphospholipid antibody: case report. J Med Assoc Thailand = Chotmaihet thangphaet. 2012;95(2):282\u20137.","journal-title":"J Med Assoc Thailand = Chotmaihet thangphaet"},{"issue":"5","key":"887_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/MBC.0000000000000545","volume":"27","author":"J Galland","year":"2016","unstructured":"Galland J, Mohamed S, Revuz S, de Maistre E, de Laat B, Marie PY, et al. Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies. Blood Coagul Fibrinolysis. 2016;27(5):580\u20132. https:\/\/doi.org\/10.1097\/MBC.0000000000000545.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"887_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0755-4982(04)98603-4","volume":"33","author":"M Sellami","year":"2004","unstructured":"Sellami M, Elloumi M, Fourati H, Ayadi N, Baklouti S. Combined hypoprothrombinemia-antiphospholipid syndrome in a patient suffering from lupus. Presse Med. 2004;33(6):391.","journal-title":"Presse Med"},{"issue":"7","key":"887_CR48","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0961203317751853","volume":"27","author":"K Cetin Gedik","year":"2018","unstructured":"Cetin Gedik K, Siddique S, Aguiar CL. Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature. Lupus. 2018;27(7):1190\u20137. https:\/\/doi.org\/10.1177\/0961203317751853.","journal-title":"Lupus"},{"issue":"1","key":"887_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1528-1157.2002.00701.x","volume":"43","author":"R Cimaz","year":"2002","unstructured":"Cimaz R, Romeo A, Scarano A, Avcin T, Viri M, Veggiotti P, et al. Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia. 2002;43(1):52\u20139.","journal-title":"Epilepsia"},{"issue":"2","key":"887_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0920-1211(01)00273-X","volume":"46","author":"K Eriksson","year":"2001","unstructured":"Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res. 2001;46(2):129\u201337.","journal-title":"Epilepsy Res"},{"issue":"8","key":"887_CR51","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.autrev.2018.01.025","volume":"17","author":"MA Islam","year":"2018","unstructured":"Islam MA, Alam F, Cavestro C, Calcii C, Sasongko TH, Levy RA, et al. Antiphospholipid antibodies in epilepsy: a systematic review and meta-analysis. Autoimmun Rev. 2018;17(8):755\u201367. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.025.","journal-title":"Autoimmun Rev"},{"issue":"13","key":"887_CR52","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1177\/0961203316651747","volume":"25","author":"MH Noureldine","year":"2016","unstructured":"Noureldine MH, Harifi G, Berjawi A, Haydar AA, Nader M, Elnawar R, et al. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Lupus. 2016;25(13):1397\u2013411. https:\/\/doi.org\/10.1177\/0961203316651747.","journal-title":"Lupus."},{"issue":"5","key":"887_CR53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.autrev.2017.03.005","volume":"16","author":"MA Islam","year":"2017","unstructured":"Islam MA, Alam F, Wong KK. Comorbid association of antiphospholipid antibodies and migraine: a systematic review and meta-analysis. Autoimmun Rev. 2017;16(5):512\u201322. https:\/\/doi.org\/10.1016\/j.autrev.2017.03.005.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"887_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/0961203317751644","volume":"27","author":"M Kopytek","year":"2018","unstructured":"Kopytek M, Natorska J, Undas A. Antiphosphatidylserine\/prothrombin (aPS\/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. Lupus. 2018;27(5):812\u20139. https:\/\/doi.org\/10.1177\/0961203317751644.","journal-title":"Lupus."},{"issue":"1","key":"887_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12026-016-8831-9","volume":"65","author":"MHA Noureldine","year":"2017","unstructured":"Noureldine MHA, Haydar AA, Berjawi A, Elnawar R, Sweid A, Khamashta MA, et al. Antiphospholipid syndrome (APS) revisited: would migraine headaches be included in future classification criteria? Immunol Res. 2017;65(1):230\u201341. https:\/\/doi.org\/10.1007\/s12026-016-8831-9.","journal-title":"Immunol Res"},{"key":"887_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1196\/annals.1361.088","volume":"1051","author":"G Sanna","year":"2005","unstructured":"Sanna G, Bertolaccini ML, Hughes GR. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. Ann N Y Acad Sci. 2005;1051:465\u201386. https:\/\/doi.org\/10.1196\/annals.1361.088.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"887_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1055\/s-0039-1692702","volume":"45","author":"A Tufano","year":"2019","unstructured":"Tufano A, Di Minno MND, Guida A, Lembo M, Di Minno G, Galderisi M. Cardiac manifestations of antiphospholipid syndrome: clinical presentation, role of cardiac imaging, and treatment strategies. Semin Thromb Hemost. 2019;45(5):468\u201377. https:\/\/doi.org\/10.1055\/s-0039-1692702.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"887_CR58","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00246-002-0273-6","volume":"24","author":"SB Clauss","year":"2003","unstructured":"Clauss SB, Manco-Johnson MJ, Quivers E, Takemoto C, Spevak PJ. Primary antiphospholipid antibody syndrome and cardiac involvement in a child. Pediatr Cardiol. 2003;24(3):292\u20134. https:\/\/doi.org\/10.1007\/s00246-002-0273-6.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"887_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1191\/0961203306lu2258cr","volume":"15","author":"M Bakshi","year":"2006","unstructured":"Bakshi M, Khemani C, Vishwanathan V, Anand RK, Khubchandani RP. Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus. Lupus. 2006;15(2):105\u20136. https:\/\/doi.org\/10.1191\/0961203306lu2258cr.","journal-title":"Lupus."},{"issue":"3","key":"887_CR60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.semarthrit.2013.07.001","volume":"43","author":"N Abisror","year":"2013","unstructured":"Abisror N, Mekinian A, Lachassinne E, Nicaise-Roland P, De Pontual L, Chollet-Martin S, et al. Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome. Semin Arthritis Rheum. 2013;43(3):348\u201351. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.07.001.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"887_CR61","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.arcped.2015.08.007","volume":"22","author":"F Lageix","year":"2015","unstructured":"Lageix F, Nicaise-Roland P, Houlier M, Zylberberg P, Dubrel M, Heulin M, et al. Association between the presence of antiphospholipid antibodies and the occurrence of autism spectrum disorder in childhood. Arch Pediatr. 2015;22(11):1140\u20136. https:\/\/doi.org\/10.1016\/j.arcped.2015.08.007.","journal-title":"Arch Pediatr"},{"key":"887_CR62","doi-asserted-by":"publisher","first-page":"935608","DOI":"10.1155\/2013\/935608","volume":"2013","author":"M Careaga","year":"2013","unstructured":"Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P. Increased anti-phospholipid antibodies in autism spectrum disorders. Mediat Inflamm. 2013;2013:935608. https:\/\/doi.org\/10.1155\/2013\/935608.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"887_CR63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00043426-200405000-00015","volume":"26","author":"A Orsino","year":"2004","unstructured":"Orsino A, Schneider R, DeVeber G, Grant R, Massicotte P, Canning P, et al. Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome. J Pediatr Hematol Oncol. 2004;26(5):327\u201330.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"887_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.autrev.2006.06.012","volume":"6","author":"W Miesbach","year":"2006","unstructured":"Miesbach W, Asherson RA, Cervera R, Shoenfeld Y, Gomez Puerta J, Bucciarelli S, et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev. 2006;6(2):94\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2006.06.012.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"887_CR65","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/art.22360","volume":"55","author":"Y Berkun","year":"2006","unstructured":"Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55(6):850\u20135. https:\/\/doi.org\/10.1002\/art.22360.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"887_CR66","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1191\/0961203303lu471oa","volume":"12","author":"LM Campos","year":"2003","unstructured":"Campos LM, Kiss MH, D'Amico EA, Silva CA. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus. 2003;12(11):820\u20136. https:\/\/doi.org\/10.1191\/0961203303lu471oa.","journal-title":"Lupus."},{"issue":"7","key":"887_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00296-004-0501-x","volume":"25","author":"J Ahluwalia","year":"2005","unstructured":"Ahluwalia J, Singh S, Garewal G. Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India. Rheumatol Int. 2005;25(7):530\u20135. https:\/\/doi.org\/10.1007\/s00296-004-0501-x.","journal-title":"Rheumatol Int"},{"issue":"6","key":"887_CR68","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1542\/peds.96.6.1040","volume":"96","author":"DE Seaman","year":"1995","unstructured":"Seaman DE, Londino AV Jr, Kwoh CK, Medsger TA Jr, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics. 1995;96(6):1040\u20135.","journal-title":"Pediatrics."},{"issue":"8","key":"887_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0961203307079036","volume":"16","author":"T Avcin","year":"2007","unstructured":"Avcin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007;16(8):627\u201333. https:\/\/doi.org\/10.1177\/0961203307079036.","journal-title":"Lupus."},{"issue":"6","key":"887_CR70","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.92.6.849","volume":"92","author":"C Molta","year":"1993","unstructured":"Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, et al. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics. 1993;92(6):849\u201353.","journal-title":"Pediatrics."},{"issue":"9","key":"887_CR71","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/rheumatology\/34.9.873","volume":"34","author":"M Gattorno","year":"1995","unstructured":"Gattorno M, Buoncompagni A, Molinari AC, Barbano GC, Morreale G, Stalla F, et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol. 1995;34(9):873\u201381.","journal-title":"Br J Rheumatol"},{"issue":"3","key":"887_CR72","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1203\/00006450-199809000-00014","volume":"44","author":"C Berube","year":"1998","unstructured":"Berube C, Mitchell L, Silverman E, David M, Saint Cyr C, Laxer R, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res. 1998;44(3):351\u20136. https:\/\/doi.org\/10.1203\/00006450-199809000-00014.","journal-title":"Pediatr Res"},{"issue":"8","key":"887_CR73","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1191\/096120398678920659","volume":"7","author":"A Gedalia","year":"1998","unstructured":"Gedalia A, Molina JF, Garcia CO, Doggett S, Espinoza LR, Gharavi AE. Anticardiolipin antibodies in childhood rheumatic disorders. Lupus. 1998;7(8):551\u20133. https:\/\/doi.org\/10.1191\/096120398678920659.","journal-title":"Lupus."},{"issue":"4","key":"887_CR74","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1001\/archpedi.1994.02170040064011","volume":"148","author":"A Ravelli","year":"1994","unstructured":"Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med. 1994;148(4):398\u2013402.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"887_CR75","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/art.23334","volume":"59","author":"T Avcin","year":"2008","unstructured":"Avcin T, Benseler SM, Tyrrell PN, Cucnik S, Silverman ED. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum. 2008;59(2):206\u201313. https:\/\/doi.org\/10.1002\/art.23334.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"887_CR76","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00296-013-2736-x","volume":"34","author":"J Ahluwalia","year":"2014","unstructured":"Ahluwalia J, Singh S, Naseem S, Suri D, Rawat A, Gupta A, et al. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India. Rheumatol Int. 2014;34(5):669\u201373. https:\/\/doi.org\/10.1007\/s00296-013-2736-x.","journal-title":"Rheumatol Int"},{"issue":"3\u20134","key":"887_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpam.2015.08.002","volume":"2","author":"SM Al-Mayouf","year":"2015","unstructured":"Al-Mayouf SM, AlSaleem A, Al-Hussain T, Al Sonbul A, AlMana H. The impact of antiphospholipid antibodies in children with lupus nephritis. Int J Pediatr Adolesc Med. 2015;2(3\u20134):147\u201351. https:\/\/doi.org\/10.1016\/j.ijpam.2015.08.002.","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"12","key":"887_CR78","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.49.12.968","volume":"49","author":"TR Southwood","year":"1990","unstructured":"Southwood TR, Roberts-Thomson PJ, Ahern MJ, Shepherd K, McEvoy R, Ziegler JB, et al. Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives. Ann Rheum Dis. 1990;49(12):968\u201372. https:\/\/doi.org\/10.1136\/ard.49.12.968.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"887_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/ard.50.9.599","volume":"50","author":"R Caporali","year":"1991","unstructured":"Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A. Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis. 1991;50(9):599\u2013601. https:\/\/doi.org\/10.1136\/ard.50.9.599.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"887_CR80","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1136\/adc.67.11.1384","volume":"67","author":"R Caporali","year":"1992","unstructured":"Caporali R, Ravelli A, Ramenghi B, Montecucco C, Martini A. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child. 1992;67(11):1384\u20135. https:\/\/doi.org\/10.1136\/adc.67.11.1384.","journal-title":"Arch Dis Child"},{"issue":"6","key":"887_CR81","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/096120339700600616","volume":"6","author":"A Andrews","year":"1997","unstructured":"Andrews A, Hickling P. Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis. Lupus. 1997;6(6):556\u20137. https:\/\/doi.org\/10.1177\/096120339700600616.","journal-title":"Lupus."},{"issue":"7","key":"887_CR82","first-page":"1367","volume":"21","author":"RE Diniz","year":"1994","unstructured":"Diniz RE, Goldenberg J, Andrade LE, Leser PG, Silva NP, Roizenblatt S, et al. Antiphospholipid antibodies in rheumatic fever chorea. J Rheumatol. 1994;21(7):1367\u20138.","journal-title":"J Rheumatol"},{"issue":"9","key":"887_CR83","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0961203308091634","volume":"17","author":"A Meglic","year":"2008","unstructured":"Meglic A, Grosek S, Benedik-Dolnicar M, Avcin T. Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome. Lupus. 2008;17(9):842\u20135. https:\/\/doi.org\/10.1177\/0961203308091634.","journal-title":"Lupus."},{"issue":"4","key":"887_CR84","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1590\/S0482-50042012000400013","volume":"52","author":"FH Souza","year":"2012","unstructured":"Souza FH, Levy-Neto M, Shinjo SK. Antiphospholipid syndrome and dermatomyositis\/polymyositis: a rare association. Rev Bras Reumatol. 2012;52(4):642\u20134.","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"887_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/096120330000900108","volume":"9","author":"Y Sherer","year":"2000","unstructured":"Sherer Y, Livneh A, Levy Y, Shoenfeld Y, Langevitz P. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome. Lupus. 2000;9(1):42\u20136. https:\/\/doi.org\/10.1177\/096120330000900108.","journal-title":"Lupus."},{"key":"887_CR86","doi-asserted-by":"publisher","first-page":"614591","DOI":"10.1155\/2014\/614591","volume":"2014","author":"F da Silva","year":"2014","unstructured":"da Silva F, de Carvalho J. Rheumatic fever associated with antiphospholipid syndrome: systematic review. J Immunol Res. 2014;2014:614591. https:\/\/doi.org\/10.1155\/2014\/614591.","journal-title":"J Immunol Res"},{"issue":"6","key":"887_CR87","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramon E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204838.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"887_CR88","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJMoa035241","volume":"349","author":"MA Crowther","year":"2003","unstructured":"Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349(12):1133\u20138. https:\/\/doi.org\/10.1056\/NEJMoa035241.","journal-title":"N Engl J Med"},{"key":"887_CR89","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fped.2017.00136","volume":"5","author":"KM Haley","year":"2017","unstructured":"Haley KM. Neonatal venous thromboembolism. Front Pediatr. 2017;5:136. https:\/\/doi.org\/10.3389\/fped.2017.00136.","journal-title":"Front Pediatr"},{"issue":"1","key":"887_CR90","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","volume":"70","author":"M Andrew","year":"1987","unstructured":"Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165\u201372.","journal-title":"Blood."},{"issue":"1","key":"887_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00043426-199021000-00019","volume":"12","author":"M Andrew","year":"1990","unstructured":"Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol\/Oncol. 1990;12(1):95\u2013104.","journal-title":"Am J Pediatr Hematol\/Oncol"},{"issue":"3","key":"887_CR92","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.siny.2006.01.005","volume":"11","author":"C Thornburg","year":"2006","unstructured":"Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med. 2006;11(3):198\u2013206. https:\/\/doi.org\/10.1016\/j.siny.2006.01.005.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"887_CR93","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.siny.2011.07.005","volume":"16","author":"U Nowak-Gottl","year":"2011","unstructured":"Nowak-Gottl U, Kurnik K, Manner D, Kenet G. Thrombophilia testing in neonates and infants with thrombosis. Semin Fetal Neonatal Med. 2011;16(6):345\u20138. https:\/\/doi.org\/10.1016\/j.siny.2011.07.005.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"887_CR94","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/blood.V72.5.1651.1651","volume":"72","author":"M Andrew","year":"1988","unstructured":"Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood. 1988;72(5):1651\u20137.","journal-title":"Blood."},{"issue":"10","key":"887_CR95","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0961203309106951","volume":"18","author":"MC Boffa","year":"2009","unstructured":"Boffa MC, Lachassinne E, Boinot C, De Carolis S, Rovere-Querini P, Avcin T, et al. European registry of babies born to mothers with antiphospholipid syndrome: a result update. Lupus. 2009;18(10):900\u20134. https:\/\/doi.org\/10.1177\/0961203309106951.","journal-title":"Lupus."},{"issue":"2","key":"887_CR96","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","volume":"72","author":"A Mekinian","year":"2013","unstructured":"Mekinian A, Lachassinne E, Nicaise-Roland P, Carbillon L, Motta M, Vicaut E, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013;72(2):217\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201167A prospective study describing the long-term outcomes of children born to mothers with APS.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"887_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-2006-939533","volume":"23","author":"M Motta","year":"2006","unstructured":"Motta M, Chirico G, Rebaioli CB, Faden D, Lojacono A, Allegri F, et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol. 2006;23(4):247\u201351. https:\/\/doi.org\/10.1055\/s-2006-939533.","journal-title":"Am J Perinatol"},{"issue":"2","key":"887_CR98","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12098-010-0228-5","volume":"78","author":"S Patra","year":"2011","unstructured":"Patra S, Krishnamurthy S, Seth A, Beri S, Aneja S. Bilateral optic neuritis in pediatric systemic lupus erythematosus with antiphospholipid antibody syndrome. Indian J Pediatr. 2011;78(2):234\u20136. https:\/\/doi.org\/10.1007\/s12098-010-0228-5.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"887_CR99","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/CDLI.1.6.667-669.1994","volume":"1","author":"BZ Garty","year":"1994","unstructured":"Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD. Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol. 1994;1(6):667\u20139.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"887_CR100","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/acr.20098","volume":"62","author":"A Ruffatti","year":"2010","unstructured":"Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT, et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res. 2010;62(3):302\u20137. https:\/\/doi.org\/10.1002\/acr.20098.","journal-title":"Arthritis Care Res"},{"issue":"8","key":"887_CR101","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0961203307079039","volume":"16","author":"MC Boffa","year":"2007","unstructured":"Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus. 2007;16(8):634\u201341. https:\/\/doi.org\/10.1177\/0961203307079039.","journal-title":"Lupus."},{"key":"887_CR102","doi-asserted-by":"publisher","first-page":"672603","DOI":"10.1155\/2014\/672603","volume":"2014","author":"MV Peixoto","year":"2014","unstructured":"Peixoto MV, de Carvalho JF, Rodrigues CE. Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review. J Immunol Res. 2014;2014:672603. https:\/\/doi.org\/10.1155\/2014\/672603.","journal-title":"J Immunol Res"},{"issue":"6","key":"887_CR103","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1515\/jpm-2014-0118","volume":"43","author":"K Jeremic","year":"2015","unstructured":"Jeremic K, Stefanovic A, Dotlic J, Stojnic J, Kadija S, Vilendecic Z, et al. Neonatal outcome in pregnant patients with antiphospholipid syndrome. J Perinat Med. 2015;43(6):761\u20138. https:\/\/doi.org\/10.1515\/jpm-2014-0118.","journal-title":"J Perinat Med"},{"issue":"2","key":"887_CR104","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1515\/jpme.1997.25.2.192","volume":"25","author":"F Botet","year":"1997","unstructured":"Botet F, Romera G, Montagut P, Figueras J, Carmona F, Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med. 1997;25(2):192\u20136.","journal-title":"J Perinat Med"},{"issue":"1","key":"887_CR105","first-page":"66","volume":"14","author":"S Tabbutt","year":"1994","unstructured":"Tabbutt S, Griswold WR, Ogino MT, Mendoza AE, Allen JB, Reznik VM. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol. 1994;14(1):66\u201370.","journal-title":"J Perinatol"},{"issue":"3","key":"887_CR106","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0961203314560207","volume":"24","author":"MP De Carolis","year":"2015","unstructured":"De Carolis MP, Salvi S, Botta A, Cocca C, Garufi C, Lanzone A, et al. Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? Lupus. 2015;24(3):231\u20134. https:\/\/doi.org\/10.1177\/0961203314560207.","journal-title":"Lupus."},{"issue":"3","key":"887_CR107","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/art.23311","volume":"59","author":"R Nacinovich","year":"2008","unstructured":"Nacinovich R, Galli J, Bomba M, Filippini E, Parrinello G, Nuzzo M, et al. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum. 2008;59(3):345\u201351. https:\/\/doi.org\/10.1002\/art.23311.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"887_CR108","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1515\/JPM.1999.025","volume":"27","author":"JA Brewster","year":"1999","unstructured":"Brewster JA, Shaw NJ, Farquharson RG. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med. 1999;27(3):183\u20137. https:\/\/doi.org\/10.1515\/JPM.1999.025.","journal-title":"J Perinat Med"},{"issue":"5","key":"887_CR109","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/0961203317694960","volume":"26","author":"C Nalli","year":"2017","unstructured":"Nalli C, Iodice A, Andreoli L, Galli J, Lojacono A, Motta M, et al. Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and\/or antiphospholipid syndrome. Lupus. 2017;26(5):552\u20138. https:\/\/doi.org\/10.1177\/0961203317694960.","journal-title":"Lupus."},{"issue":"1","key":"887_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000034","volume":"1","author":"W Marder","year":"2014","unstructured":"Marder W, Romero VC, Ganser MA, Hyzy MA, Gordon C, McCune WJ, et al. Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies. Lupus Sci Med. 2014;1(1):e000034. https:\/\/doi.org\/10.1136\/lupus-2014-000034.","journal-title":"Lupus Sci Med"},{"issue":"1","key":"887_CR111","first-page":"45","volume":"10","author":"Y Berkun","year":"2008","unstructured":"Berkun Y, Kenet G. Pediatric antiphospholipid syndrome. Isr Med Assoc J. 2008;10(1):45\u20137.","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"887_CR112","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.semarthrit.2014.04.003","volume":"44","author":"O Gordon","year":"2014","unstructured":"Gordon O, Almagor Y, Fridler D, Mandel A, Qutteineh H, Yanir A, et al. De novo neonatal antiphospholipid syndrome: a case report and review of the literature. Semin Arthritis Rheum. 2014;44(2):241\u20135. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.04.003.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"887_CR113","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/0961203314531842","volume":"23","author":"Y Berkun","year":"2014","unstructured":"Berkun Y, Simchen MJ, Strauss T, Menashcu S, Padeh S, Kenet G. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome? Lupus. 2014;23(10):986\u201393. https:\/\/doi.org\/10.1177\/0961203314531842.","journal-title":"Lupus."},{"issue":"4","key":"887_CR114","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/rheumatology\/kem011","volume":"46","author":"D Paro-Panjan","year":"2007","unstructured":"Paro-Panjan D, Kitanovski L, Avcin T. Neonatal antiphospholipid syndrome associated with heterozygous methylentetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology. 2007;46(4):720\u20131. https:\/\/doi.org\/10.1093\/rheumatology\/kem011.","journal-title":"Rheumatology."},{"issue":"5","key":"887_CR115","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/096120339600500516","volume":"5","author":"RA Asherson","year":"1996","unstructured":"Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus. 1996;5(5):414\u20137. https:\/\/doi.org\/10.1177\/096120339600500516.","journal-title":"Lupus."},{"issue":"12","key":"887_CR116","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00431-011-1548-9","volume":"170","author":"M Cabral","year":"2011","unstructured":"Cabral M, Abadesso C, Conde M, Almeida H, Carreiro H. Catastrophic antiphospholipid syndrome: first signs in the neonatal period. Eur J Pediatr. 2011;170(12):1577\u201383. https:\/\/doi.org\/10.1007\/s00431-011-1548-9.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"887_CR117","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530\u20134. https:\/\/doi.org\/10.1191\/0961203303lu394oa.","journal-title":"Lupus."},{"issue":"8","key":"887_CR118","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1136\/ard.2004.025759","volume":"64","author":"R Cervera","year":"2005","unstructured":"Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2005;64(8):1205\u20139. https:\/\/doi.org\/10.1136\/ard.2004.025759.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"887_CR119","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","volume":"10","author":"D Erkan","year":"2010","unstructured":"Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev. 2010;10(2):74\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2010.08.005.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"887_CR120","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jpeds.2012.03.042","volume":"161","author":"MJ Manco-Johnson","year":"2012","unstructured":"Manco-Johnson MJ, Wang M, Goldenberg NA, Soep J, Gibson E, Knoll CM, et al. Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. J Pediatr. 2012;161(4):682\u20138 e1. https:\/\/doi.org\/10.1016\/j.jpeds.2012.03.042.","journal-title":"J Pediatr"},{"issue":"11","key":"887_CR121","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","volume":"14","author":"M Garcia-Carrasco","year":"2015","unstructured":"Garcia-Carrasco M, Mendoza-Pinto C, Macias-Diaz S, Vazquez de Lara F, Etchegaray-Morales I, Galvez-Romero JL, et al. The role of infectious diseases in the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2015;14(11):1066\u201371. https:\/\/doi.org\/10.1016\/j.autrev.2015.07.009.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"887_CR122","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V5111882","volume":"5","author":"VR Peddi","year":"1995","unstructured":"Peddi VR, Kant KS. Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency. J Am Soc Nephrol. 1995;5(11):1882\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"887_CR123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/096120339700600110","volume":"6","author":"N Hudson","year":"1997","unstructured":"Hudson N, Duffy CM, Rauch J, Paquin JD, Esdaile JM. Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency. Lupus. 1997;6(1):68\u201371. https:\/\/doi.org\/10.1177\/096120339700600110.","journal-title":"Lupus"},{"issue":"6","key":"887_CR124","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","volume":"80","author":"RA Asherson","year":"2001","unstructured":"Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine. 2001;80(6):355\u201377.","journal-title":"Medicine."},{"issue":"2","key":"887_CR125","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.autrev.2013.10.004","volume":"13","author":"H Berman","year":"2014","unstructured":"Berman H, Rodriguez-Pinto I, Cervera R, Gregory S, de Meis E, Rodrigues CE, et al. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the \"CAPS Registry\". Autoimmun Rev. 2014;13(2):157\u201362. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.004A descriptive analysis of pediatric patients from the CAPS registry.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"887_CR126","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.autrev.2014.10.019","volume":"14","author":"L Arnaud","year":"2015","unstructured":"Arnaud L, Mathian A, Devilliers H, Ruffatti A, Tektonidou M, Forastiero R, et al. Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. Autoimmun Rev. 2015;14(3):192\u2013200. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.019.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"887_CR127","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","volume":"13","author":"L Arnaud","year":"2014","unstructured":"Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev. 2014;13(3):281\u201391. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.014.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"887_CR128","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/art.27289","volume":"62","author":"H Jung","year":"2010","unstructured":"Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, et al. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis Rheum. 2010;62(3):863\u20138. https:\/\/doi.org\/10.1002\/art.27289.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"887_CR129","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","volume":"14","author":"C Belizna","year":"2015","unstructured":"Belizna C. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. Autoimmun Rev. 2015;14(4):358\u201362. https:\/\/doi.org\/10.1016\/j.autrev.2014.12.006.","journal-title":"Autoimmun Rev"},{"key":"887_CR130","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","volume":"75","author":"ML Bertolaccini","year":"2016","unstructured":"Bertolaccini ML, Contento G, Lennen R, Sanna G, Blower PJ, Ma MT, et al. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun. 2016;75:30\u20138. https:\/\/doi.org\/10.1016\/j.jaut.2016.04.008.","journal-title":"J Autoimmun"},{"issue":"11","key":"887_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206814","volume":"13","author":"G Urbanski","year":"2018","unstructured":"Urbanski G, Caillon A, Poli C, Kauffenstein G, Begorre MA, Loufrani L, et al. Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome. PLoS One. 2018;13(11):e0206814. https:\/\/doi.org\/10.1371\/journal.pone.0206814.","journal-title":"PLoS One"},{"issue":"1","key":"887_CR132","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12026-016-8812-z","volume":"65","author":"E Nuri","year":"2017","unstructured":"Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A, et al. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome. Immunol Res. 2017;65(1):17\u201324. https:\/\/doi.org\/10.1007\/s12026-016-8812-z.","journal-title":"Immunol Res"},{"issue":"2","key":"887_CR133","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/0961203310395803","volume":"20","author":"G Ruiz-Irastorza","year":"2011","unstructured":"Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R, et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011;20(2):206\u201318. https:\/\/doi.org\/10.1177\/0961203310395803.","journal-title":"Lupus."},{"issue":"25","key":"887_CR134","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1182\/bloodadvances.2017008185","volume":"1","author":"WG Jackson","year":"2017","unstructured":"Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT, Antiphospholipid Syndrome Alliance for Clinical T, et al. Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy. Blood Adv. 2017;1(25):2320\u20134. https:\/\/doi.org\/10.1182\/bloodadvances.2017008185.","journal-title":"Blood Adv"},{"issue":"8","key":"887_CR135","first-page":"1560","volume":"31","author":"JA Giron-Gonzalez","year":"2004","unstructured":"Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol. 2004;31(8):1560\u20137.","journal-title":"J Rheumatol"},{"issue":"12","key":"887_CR136","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","volume":"15","author":"Ignasi Rodr\u00edguez-Pint\u00f3","year":"2016","unstructured":"Rodriguez-Pinto I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016;15(12):1120\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.010A descriptive analysis of 500 patients enrolled in the International CAPS Registry.","journal-title":"Autoimmunity Reviews"},{"issue":"6","key":"887_CR137","doi-asserted-by":"publisher","first-page":"e1523","DOI":"10.1542\/peds.2009-2939","volume":"125","author":"E Iglesias-Jimenez","year":"2010","unstructured":"Iglesias-Jimenez E, Camacho-Lovillo M, Falcon-Neyra D, Lirola-Cruz J, Neth O. Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab. Pediatrics. 2010;125(6):e1523\u20138. https:\/\/doi.org\/10.1542\/peds.2009-2939.","journal-title":"Pediatrics."},{"issue":"4","key":"887_CR138","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/pbc.21878","volume":"52","author":"AA Nageswara Rao","year":"2009","unstructured":"Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr Blood Cancer. 2009;52(4):536\u20138. https:\/\/doi.org\/10.1002\/pbc.21878.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"887_CR139","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","volume":"12","author":"H Berman","year":"2013","unstructured":"Berman H, Rodriguez-Pinto I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, et al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev. 2013;12(11):1085\u201390. https:\/\/doi.org\/10.1016\/j.autrev.2013.05.004A descriptive analysis of the use of rituximab in pediatric CAPS.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"887_CR140","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.autrev.2019.03.015","volume":"18","author":"A Ruffatti","year":"2019","unstructured":"Ruffatti A, Tarzia V, Fedrigo M, Calligaro A, Favaro M, Macor P, et al. Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab. Autoimmun Rev. 2019;18(5):561\u20133. https:\/\/doi.org\/10.1016\/j.autrev.2019.03.015.","journal-title":"Autoimmun Rev"},{"key":"887_CR141","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3389\/fimmu.2019.00773","volume":"10","author":"PA Lonati","year":"2019","unstructured":"Lonati PA, Scavone M, Gerosa M, Borghi MO, Pregnolato F, Curreli D, et al. Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome. Front Immunol. 2019;10:773. https:\/\/doi.org\/10.3389\/fimmu.2019.00773.","journal-title":"Front Immunol"},{"key":"887_CR142","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fimmu.2019.00449","volume":"10","author":"S Chaturvedi","year":"2019","unstructured":"Chaturvedi S, Brodsky RA, McCrae KR. Complement in the pathophysiology of the antiphospholipid syndrome. Front Immunol. 2019;10:449. https:\/\/doi.org\/10.3389\/fimmu.2019.00449.","journal-title":"Front Immunol"},{"issue":"40","key":"887_CR143","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012584","volume":"97","author":"P Rovere-Querini","year":"2018","unstructured":"Rovere-Querini P, Canti V, Erra R, Bianchi E, Slaviero G, D'Angelo A, et al. Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: a case report. Medicine. 2018;97(40):e12584. https:\/\/doi.org\/10.1097\/MD.0000000000012584.","journal-title":"Medicine."},{"issue":"11","key":"887_CR144","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/rheumatology\/key228","volume":"57","author":"M Guillot","year":"2018","unstructured":"Guillot M, Rafat C, Buob D, Coppo P, Jamme M, Rondeau E, et al. Eculizumab for catastrophic antiphospholipid syndrome-a case report and literature review. Rheumatology. 2018;57(11):2055\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/key228.","journal-title":"Rheumatology."},{"issue":"6","key":"887_CR145","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/RHU.0000000000000290","volume":"21","author":"TA Zikos","year":"2015","unstructured":"Zikos TA, Sokolove J, Ahuja N, Berube C. Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome. J Clin Rheumatol. 2015;21(6):311\u20133. https:\/\/doi.org\/10.1097\/RHU.0000000000000290.","journal-title":"J Clin Rheumatol"},{"key":"887_CR146","doi-asserted-by":"publisher","first-page":"704371","DOI":"10.1155\/2014\/704371","volume":"2014","author":"M Strakhan","year":"2014","unstructured":"Strakhan M, Hurtado-Sbordoni M, Galeas N, Bakirhan K, Alexis K, Elrafei T. 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature. Case Rep Hematol. 2014;2014:704371. https:\/\/doi.org\/10.1155\/2014\/704371.","journal-title":"Case Rep Hematol"},{"issue":"8","key":"887_CR147","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/art.34440","volume":"64","author":"I Shapira","year":"2012","unstructured":"Shapira I, Andrade D, Allen SL, Salmon JE. Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum. 2012;64(8):2719\u201323. https:\/\/doi.org\/10.1002\/art.34440.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"887_CR148","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/0961203307077993","volume":"16","author":"T Tarr","year":"2007","unstructured":"Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus. 2007;16(5):324\u20138. https:\/\/doi.org\/10.1177\/0961203307077993.","journal-title":"Lupus."},{"issue":"10","key":"887_CR149","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/0961203309106832","volume":"18","author":"R Cervera","year":"2009","unstructured":"Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889\u201393. https:\/\/doi.org\/10.1177\/0961203309106832.","journal-title":"Lupus."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-020-0887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T07:29:15Z","timestamp":1665991755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-020-0887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-0887-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"3 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Avcin reports grants from Slovenian Research Agency, during the conduct of the study; personal fees from AbbVie, personal fees from Octapharma, personal fees from Shire, outside the submitted work.Dr. SOYBILGIC has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"9"}}